Ebola virus disease: societal challenges and new treatments (Q38388679)

2 September 2017

1 reference

title

Ebola virus disease: societal challenges and new treatments (English)

1 reference

2 September 2017

main subject

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

author name string

A Mirazimi

series ordinal

1

1 reference

2 September 2017

language of work or name

English

0 references

publication date

5 July 2015

1 reference

Journal of Internal Medicine

2 September 2017

published in

1 reference

2 September 2017

volume

278

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

227-237

1 reference

Influenza outbreak among health care workers in an avian influenza (H5N1)-endemic setting

2 September 2017

cites work

1 reference

Report details lessons from SARS outbreak

21 January 2018

1 reference

Prediction of a Rift Valley fever outbreak

21 January 2018

1 reference

Crimean-Congo haemorrhagic fever

21 January 2018

1 reference

Climate and vectorborne diseases

21 January 2018

1 reference

Global change and human vulnerability to vector-borne diseases

21 January 2018

1 reference

Global trends in emerging infectious diseases

21 January 2018

1 reference

Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography

21 January 2018

1 reference

Differentiation of filoviruses by electron microscopy

21 January 2018

1 reference

Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory

21 January 2018

1 reference

Current perspectives on the phylogeny of Filoviridae

21 January 2018

1 reference

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations

21 January 2018

1 reference

Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences

21 January 2018

1 reference

Genetics-based classification of filoviruses calls for expanded sampling of genomic sequences

21 January 2018

1 reference

The origin and evolution of Ebola and Marburg viruses

21 January 2018

1 reference

Filoviruses are ancient and integrated into mammalian genomes

21 January 2018

1 reference

21 January 2018

Ebola haemorrhagic fever

1 reference

The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer

21 January 2018

1 reference

Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein

21 January 2018

1 reference

Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.

21 January 2018

1 reference

Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography.

21 January 2018

1 reference

The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein

21 January 2018

1 reference

Ebola virus VP30 is an RNA binding protein

21 January 2018

1 reference

Ebola virus transcription activator VP30 is a zinc-binding protein

21 January 2018

1 reference

Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation

21 January 2018

1 reference

The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals

21 January 2018

1 reference

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.

21 January 2018

1 reference

The Ebola virus VP35 protein functions as a type I IFN antagonist.

21 January 2018

1 reference

VP24 of Marburg virus influences formation of infectious particles

21 January 2018

1 reference

Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription

21 January 2018

1 reference

21 January 2018

1 reference

The ebolavirus VP24 interferon antagonist: know your enemy

21 January 2018

1 reference

The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold

21 January 2018

1 reference

Shed GP of Ebola virus triggers immune activation and increased vascular permeability

21 January 2018

1 reference

Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils

21 January 2018

1 reference

Evidence against Ebola virus sGP binding to human neutrophils by a specific receptor

21 January 2018

1 reference

Delta-peptide is the carboxy-terminal cleavage fragment of the nonstructural small glycoprotein sGP of Ebola virus

21 January 2018

1 reference

Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife

21 January 2018

1 reference

Transmission dynamics and control of Ebola virus disease (EVD): a review

21 January 2018

1 reference

Ebola fever: reconciling planning with risk in U.S. hospitals

21 January 2018

1 reference

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda

21 January 2018

1 reference

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections

21 January 2018

1 reference

Emergence of Zaire Ebola Virus Disease in Guinea

21 January 2018

1 reference

Investigating the zoonotic origin of the West African Ebola epidemic

21 January 2018

1 reference

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

21 January 2018

1 reference

A clinical guide to viral haemorrhagic fevers: Ebola, Marburg and Lassa

21 January 2018

1 reference

Clinical presentation and management of severe Ebola virus disease

21 January 2018

1 reference

West African Ebola epidemic after one year--slowing but not yet under control

21 January 2018

1 reference

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit

21 January 2018

1 reference

Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses

21 January 2018

1 reference

Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure

21 January 2018

1 reference

Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit

21 January 2018

1 reference

Hemorrhagic fever viruses as biological weapons: medical and public health management

21 January 2018

1 reference

Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology.

21 January 2018

1 reference

Assessment of the risk of Ebola virus transmission from bodily fluids and fomites

21 January 2018

1 reference

A case of severe Ebola virus infection complicated by gram-negative septicemia

21 January 2018

1 reference

Ebola--underscoring the global disparities in health care resources

21 January 2018

1 reference

Outbreak of ebola virus disease in Guinea: where ecology meets economy

21 January 2018

1 reference

Strategies for containing Ebola in West Africa

21 January 2018

1 reference

Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned

21 January 2018

1 reference

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

21 January 2018

1 reference

First Ebola treatment is approved by WHO.

21 January 2018

1 reference

Ebola: a call for blood transfusion strategy in sub-Saharan Africa

21 January 2018

1 reference

Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies

21 January 2018

1 reference

US signs contract with ZMapp maker to accelerate development of the Ebola drug

21 January 2018

1 reference

Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses

21 January 2018

1 reference

In vitro efficacy of brincidofovir against variola virus

21 January 2018

1 reference

Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus

21 January 2018

1 reference

Development of CMX001 for the Treatment of Poxvirus Infections

21 January 2018

1 reference

Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase

21 January 2018

1 reference

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever

21 January 2018

1 reference

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

21 January 2018

1 reference

Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment

21 January 2018

1 reference

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

21 January 2018

1 reference

Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model

21 January 2018

1 reference

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

21 January 2018

1 reference

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

21 January 2018

1 reference

FDA allows second experimental drug to be tested in Ebola patients

21 January 2018

1 reference

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

21 January 2018

1 reference

Advanced morpholino oligomers: a novel approach to antiviral therapy

21 January 2018

1 reference

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

21 January 2018

1 reference

Is Canada patent deal obstructing Ebola vaccine development?

21 January 2018

1 reference

Chimpanzee Adenovirus Vector Ebola Vaccine — Preliminary Report

21 January 2018

1 reference

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus

21 January 2018

1 reference

The UK foot-and-mouth disease outbreak — the aftermath

21 January 2018

1 reference

Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus

21 January 2018

1 reference

12 December 2020

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

1 reference

12 December 2020

1 reference

12 December 2020

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

1 reference

12 December 2020

Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread

1 reference

12 December 2020

Rift Valley fever virus

1 reference

12 December 2020

Identifiers

DOI

10.1111/JOIM.12386

1 reference

release_4zfj4lhtcbbn7nwybsy46fo3di

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4zfj4lhtcbbn7nwybsy46fo3di

24 November 2022

mapped directly with Wikidata item

1 reference